Molecular Biometrics Inc. (MBAI) Stock Analysis & DCF Valuation

Molecular Biometrics Inc. logo

MBAI · OTC Pink ·

Buy

High confidence

Molecular Biometrics Inc. is a developmental-stage company focused on medical diagnostics. Trading on OTC Pink, it carries high volatility and speculative risk.

Molecular Biometrics Inc. Intrinsic Value & DCF Valuation

Our discounted cash flow (DCF) model estimates Molecular Biometrics Inc. fair value at $NaN per share, compared to the current market price of $NaN. This implies +8767.5% upside from today's price.

Fair Value (DCF) $NaN
Current Market Price $NaN
Upside / Downside +8767.5%

MBAI Key Financial Metrics

Market Cap $2.08M
P/E Ratio N/A
Dividend Yield 0.00%
Analyst Target Price $0.00

Molecular Biometrics Inc. Long-Term Stock Outlook

The long-term outlook is extremely uncertain. Success hinges entirely on realizing the potential of its core technology, which is currently highly speculative given its OTC status.

Bullish Factors

  • [object Object]
  • [object Object]
  • [object Object]

Key Risks

  • [object Object]
  • [object Object]
  • [object Object]

MBAI Analyst Sentiment & Market Consensus

There is virtually no analyst coverage for MBAI due to its micro-cap status on the OTC market. Sentiment is driven purely by retail speculation and operational news.

Should You Buy MBAI Stock?

Recommendation: Buy High confidence

No recommendation provided

Frequently Asked Questions

Is MBAI a good stock to buy?

Based on our AI analysis, Molecular Biometrics Inc. (MBAI) is rated as Buy with high confidence. Molecular Biometrics Inc. is a developmental-stage company focused on medical diagnostics. Trading on OTC Pink, it carries high volatility and speculative risk.

What is MBAI stock price target?

Our DCF valuation model estimates Molecular Biometrics Inc. (MBAI) fair value at $NaN, suggesting +8767.5% downside potential from current price of $NaN.

What is MBAI fair value?

The fair value for Molecular Biometrics Inc. (MBAI) is estimated at $NaN based on discounted cash flow (DCF) analysis. This represents +8767.5% downside from the current price.

*This analysis is for informational purposes only and should not be taken as financial advice.*

© 2025 stockpickr - AI-Powered Stock Analysis

View more stock analyses